161 related articles for article (PubMed ID: 11006482)
21. The effect of racemic gossypol and at-101 on angiogenic profile of ovcar-3 cells: a preliminary molecular framework for gossypol enantiomers.
Varol U; Karaca B; Tunali D; Degirmenci M; Cirak Y; Purcu DU; Uzunoglu S; Sezgin C; Karabulut B; Sanli UA; Uslu R
Exp Oncol; 2009 Dec; 31(4):220-5. PubMed ID: 20010531
[TBL] [Abstract][Full Text] [Related]
22. Chiral gossypol derivatives: evaluation of their anticancer activity and molecular modeling.
Zhang L; Jiang H; Cao X; Zhao H; Wang F; Cui Y; Jiang B
Eur J Med Chem; 2009 Oct; 44(10):3961-72. PubMed ID: 19447525
[TBL] [Abstract][Full Text] [Related]
23. Recent advances in gossypol derivatives and analogs: a chemistry and biology view.
Lu Y; Li J; Dong CE; Huang J; Zhou HB; Wang W
Future Med Chem; 2017 Jul; 9(11):1243-1275. PubMed ID: 28722469
[TBL] [Abstract][Full Text] [Related]
24. Design and synthesis of a gossypol derivative with improved antitumor activities.
Zhan Y; Jia G; Wu D; Xu Y; Xu L
Arch Pharm (Weinheim); 2009 Apr; 342(4):223-9. PubMed ID: 19340835
[TBL] [Abstract][Full Text] [Related]
25. Novel O-glycosidic gossypol isomers and their bioactivities.
Yin J; Jin L; Chen F; Wang X; Kitaygorodskiy A; Jiang Y
Carbohydr Res; 2011 Oct; 346(14):2070-4. PubMed ID: 21788013
[TBL] [Abstract][Full Text] [Related]
26. [Suppressive effect of Gossypol, Gossypolone and serum from Gossypol treated rats on steroidogenesis in cultured porcine granulosa cells].
Ohmura H
Nihon Ika Daigaku Zasshi; 1996 Jun; 63(3):181-9. PubMed ID: 8707919
[TBL] [Abstract][Full Text] [Related]
27. Anti-tumor compounds identification from gossypol Groebke imidazopyridine product.
Wang W; Lu Y; Chen E; Shen K; Li J
Bioorg Chem; 2021 Sep; 114():105146. PubMed ID: 34328859
[TBL] [Abstract][Full Text] [Related]
28. Selected approaches for rational drug design and high throughput screening to identify anti-cancer molecules.
Hedvat M; Emdad L; Das SK; Kim K; Dasgupta S; Thomas S; Hu B; Zhu S; Dash R; Quinn BA; Oyesanya RA; Kegelman TP; Sokhi UK; Sarkar S; Erdogan E; Menezes ME; Bhoopathi P; Wang XY; Pomper MG; Wei J; Wu B; Stebbins JL; Diaz PW; Reed JC; Pellecchia M; Sarkar D; Fisher PB
Anticancer Agents Med Chem; 2012 Nov; 12(9):1143-55. PubMed ID: 22931411
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and evaluation of Apogossypol atropisomers as potential Bcl-xL antagonists.
Wei J; Rega MF; Kitada S; Yuan H; Zhai D; Risbood P; Seltzman HH; Twine CE; Reed JC; Pellecchia M
Cancer Lett; 2009 Jan; 273(1):107-13. PubMed ID: 18782651
[TBL] [Abstract][Full Text] [Related]
30. Adverse effects of gossypol analogs on TM4 cell mitochondrial function.
Tanphaichitr N; Fitzgerald LM
Contraception; 1989 Jun; 39(6):677-85. PubMed ID: 2752754
[TBL] [Abstract][Full Text] [Related]
31. BI-97C1, an optically pure Apogossypol derivative as pan-active inhibitor of antiapoptotic B-cell lymphoma/leukemia-2 (Bcl-2) family proteins.
Wei J; Stebbins JL; Kitada S; Dash R; Placzek W; Rega MF; Wu B; Cellitti J; Zhai D; Yang L; Dahl R; Fisher PB; Reed JC; Pellecchia M
J Med Chem; 2010 May; 53(10):4166-76. PubMed ID: 20443627
[TBL] [Abstract][Full Text] [Related]
32. Growth inhibitory effects of gossypol and related compounds on fungal cotton root pathogens.
Mellon JE; Dowd MK; Beltz SB; Moore GG
Lett Appl Microbiol; 2014 Aug; 59(2):161-8. PubMed ID: 24713043
[TBL] [Abstract][Full Text] [Related]
33. Cancer-Cell-Specific Drug Delivery by a Tumor-Homing CPP-Gossypol Conjugate Employing a Tracelessly Cleavable Linker.
Maity SK; Stahl P; Hensel A; Knauer S; Hirschhäuser C; Schmuck C
Chemistry; 2020 Mar; 26(14):3010-3015. PubMed ID: 31840306
[TBL] [Abstract][Full Text] [Related]
34. Stability and antioxidant activity of gossypol derivative immobilized on N-polyvinylpyrrolidone.
Ionov M; Gordiyenko NV; Zukowska I; Tokhtaeva E; Mareninova OA; Baram N; Ziyaev K; Rezhepov K; Zamaraeva M
Int J Biol Macromol; 2012 Dec; 51(5):908-14. PubMed ID: 22910577
[TBL] [Abstract][Full Text] [Related]
35. Inhibitory effects of gossypol analogs on human sperm motility.
Tanphaichitr N; Agulnick A; Hill JA
Contraception; 1989 Jun; 39(6):687-97. PubMed ID: 2752755
[TBL] [Abstract][Full Text] [Related]
36. HPLC preparation of the chiral forms of 6-methoxy-gossypol and 6,6'-dimethoxy-gossypol.
Dowd MK; Pelitire SM
J Chromatogr B Analyt Technol Biomed Life Sci; 2008 May; 867(1):69-77. PubMed ID: 18407810
[TBL] [Abstract][Full Text] [Related]
37. Natural Product Gossypol and its Derivatives in Precision Cancer Medicine.
Zeng Y; Ma J; Xu L; Wu D
Curr Med Chem; 2019; 26(10):1849-1873. PubMed ID: 28545375
[TBL] [Abstract][Full Text] [Related]
38. Apogossypolone, derivative of gossypol, mobilizes endogenous copper in human peripheral lymphocytes leading to oxidative DNA breakage.
Zubair H; Khan HY; Ullah MF; Ahmad A; Wu D; Hadi SM
Eur J Pharm Sci; 2012 Aug; 47(1):280-6. PubMed ID: 22554693
[TBL] [Abstract][Full Text] [Related]
39. Sperm motility loss induced by gossypol: relation with OH. scavengers, motile stimulators and malondialdehyde production.
Fornés MW; Barbieri AM; Burgos MH
Biochem Biophys Res Commun; 1993 Sep; 195(3):1289-93. PubMed ID: 8216260
[TBL] [Abstract][Full Text] [Related]
40. Solid-phase combinatorial synthesis and cytotoxicity of 3-aryl-2,4-quinazolindiones.
Choo HY; Kim M; Lee SK; Kim SW; Chung IK
Bioorg Med Chem; 2002 Mar; 10(3):517-23. PubMed ID: 11814837
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
